Nov 22, 2016 07:24 am UTC| Business
STOCKHOLM, Sweden, Nov. 22, 2016 -- Karolinska Development's portfolio company Umecrine Cognition AB, today announces the closing of a financing round raising SEK 45 million (US$4.9 million) in accordance with the...
Discover the latest version of ESI's system modeling solution, SimulationX 3.8
Nov 22, 2016 07:07 am UTC| Business
Paris, France, Nov. 22, 2016 -- Discover the latest version of ESI's system modeling solution, SimulationX 3.8 Industry proven solution delivers additional capabilities to support biomedical applications and smart...
Zodiac Aerospace: Recovery and transformation under way
Nov 22, 2016 06:10 am UTC| Business
Plaisir, France, Nov. 22, 2016 -- Recovery and transformation under way Zodiac Aerospace: results for the 2015/2016 fiscal year The 2015/2016 was marked by high level of cost overruns incurred by Aircraft...
CMS Announces CLFS for 2017 – CareDx’s AlloMap Reimbursement Updated; Rate to Remain at $2,821
Nov 22, 2016 02:10 am UTC| Business
BRISBANE, Calif., Nov. 21, 2016 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions...
Federal Home Loan Bank of San Francisco Announces 2016 Director Election Results
Nov 22, 2016 01:34 am UTC| Business
SAN FRANCISCO, Nov. 21, 2016 -- The Federal Home Loan Bank of San Francisco announced today the results of its 2016 director elections. The Bank’s members re-elected Robert F. Nielsen to a nonmember public interest...
Is the investment in private health insurance worthwhile?
Nov 22, 2016 01:27 am UTC| Insights & Views Business
A frequent topic of conversation at any social or workplace gathering is the cost and unfairness of private health insurance. Despite guaranteed free treatment in public hospitals, we are both conditioned and persuaded to...
The U.S. FDA approves Soliqua(TM) 100/33 for the treatment of adults with type 2 diabetes
Nov 22, 2016 00:40 am UTC| Business
Glostrup, Denmark, Nov. 22, 2016 -- Company announcement - No. 46 / 2016 The U.S. FDA approves Soliqua(TM) 100/33 for the treatment of adults with type 2 diabetes FDA approval triggers a $25 million...